Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann’s refined classification

PURPOSE: Triple-negative breast cancer (TNBC) requires the identification of reliable predictors of response to neoadjuvant chemotherapy (NACT). For this purpose, we aimed to evaluate the performance of the TNBCtype-4 classifier in a cohort of TNBC patients treated with neoadjuvant carboplatin and d...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Cancer Res
Главные авторы: Echavarria, Isabel, López-Tarruella, Sara, Picornell, Antoni, García-Saenz, Jose Ángel, Yolanda Jerez, Y, Hoadley, Katherine, Gómez, Henry L, Moreno, Fernando, Del Monte-Millan, María, Márquez-Rodas, Iván, Alvarez, Enrique, Ramos-Medina, Rocío, Gayarre, Javier, Massarrah, Tatiana, Ocaña, Inmaculada, Cebollero, María, Fuentes, Hugo, Barnadas, Agusti, Ballesteros, Ana Isabel, Bohn, Uriel, Perou, Charles M, Martin, Miguel
Формат: Artigo
Язык:Inglês
Опубликовано: 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5899625/
https://ncbi.nlm.nih.gov/pubmed/29378733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-1912
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы